Vir Biotechnology, Inc. (VIR) P/S ratio

P/S ratio today
19.3×

Vir Biotechnology, Inc. (VIR) trades at 19.3× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 12.6×. That is 20.0% lower than the 15.7× of fiscal 2024. Figures as of 18 Nov 2026, 11:43 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
19.3×
P/S ratio, fiscal 2025
12.6×
Change on fiscal 2024
−20.0%
Highest on record
47.2×fiscal 2019
Lowest on record
2.2×fiscal 2022
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Vir Biotechnology, Inc. P/S ratio, in more detail

Today's figure is 53.4% above the fiscal 2025 year-end.

Across the 7 fiscal year-ends on record (2019–2025), the highest was 47.2× in fiscal 2019 and the lowest 2.2× in fiscal 2022. Today's P/S ratio is higher than at 57% of the 7 fiscal year-ends on record; their median is 15.7×.

History · 7 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Vir Biotechnology, Inc. P/S ratio, year by year

Vir Biotechnology, Inc. (VIR) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today19.3×—$9.25—
202512.6× 20.0% down$6.03$0.48
202415.7× 54.1% down$7.34$0.47
202334.2× 1,482.6% up$10.06$0.29
20222.2× 57.7% down$25.31$11.72
20215.1× 87.8% down$41.87$8.21
202041.8× 11.4% down$26.78$0.64
201947.2×—$12.57$0.27

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

More on VIR

Vir Biotechnology, Inc., figure by figure

Vir Biotechnology, Inc. (VIR) overview: price, valuation and scorecard

Vir Biotechnology, Inc. P/S ratio: questions and answers

What is Vir Biotechnology, Inc.'s P/S ratio?

Vir Biotechnology, Inc. (VIR) trades at 19.3× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 12.6×. That is 20.0% lower than the 15.7× of fiscal 2024.

Is Vir Biotechnology, Inc.'s P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 57% of the 7 fiscal year-ends on record; their median is 15.7×.

What are the highest and lowest P/S ratio figures on record for Vir Biotechnology, Inc.?

Across the 7 fiscal year-ends on record (2019–2025), the highest was 47.2× in fiscal 2019 and the lowest 2.2× in fiscal 2022.

How is Vir Biotechnology, Inc.'s P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Vir Biotechnology, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Vir Biotechnology, Inc. (VIR) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/VIR/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.